Skip to main content

Table 1 Clinical-pathological features of the 20 liver cancer patients

From: Epigenetic silencing of glutaminase 2 in human liver and colon cancers

Characteristics Gls2-methylated Gls2-unmethylated
Age, years 51 ± 10.6 53 ± 12.9
(n) (13) (7)
Gender   
  M 11 (84.6%) 6 (85.7%)
  F 2 (15.4) 1 (14.3%)
HBV infection   
  Positive 10 (76.9%) 5 (71.4%)
  Negative 3 (23.1%) 2 (28.6%)
AFP level   
  Normal 4 (30.8%) 3 (42.9%)
  Abnormal 9 (69.2%) 4 (57.1%)
TNM stage   
  I-II 3 (23.1%) 2 (28.6%)
  III-IV 10 (76.9%) 5 (71.4%)